Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Heterogeneous cardiac sympathetic innervation gradients promote arrhythmogenesis in murine dilated cardiomyopathy
Al-Hassan J. Dajani, … , Zhilin Qu, Olujimi A. Ajijola
Al-Hassan J. Dajani, … , Zhilin Qu, Olujimi A. Ajijola
Published October 10, 2023
Citation Information: JCI Insight. 2023;8(22):e157956. https://doi.org/10.1172/jci.insight.157956.
View: Text | PDF
Research Article Cardiology

Heterogeneous cardiac sympathetic innervation gradients promote arrhythmogenesis in murine dilated cardiomyopathy

  • Text
  • PDF
Abstract

Ventricular arrhythmias (VAs) in heart failure are enhanced by sympathoexcitation. However, radiotracer studies of catecholamine uptake in failing human hearts demonstrate a proclivity for VAs in patients with reduced cardiac sympathetic innervation. We hypothesized that this counterintuitive finding is explained by heterogeneous loss of sympathetic nerves in the failing heart. In a murine model of dilated cardiomyopathy (DCM), delayed PET imaging of sympathetic nerve density using the catecholamine analog [11C]meta-Hydroxyephedrine demonstrated global hypoinnervation in ventricular myocardium. Although reduced, sympathetic innervation in 2 distinct DCM models invariably exhibited transmural (epicardial to endocardial) gradients, with the endocardium being devoid of sympathetic nerve fibers versus controls. Further, the severity of transmural innervation gradients was correlated with VAs. Transmural innervation gradients were also identified in human left ventricular free wall samples from DCM versus controls. We investigated mechanisms underlying this relationship by in silico studies in 1D, 2D, and 3D models of failing and normal human hearts, finding that arrhythmogenesis increased as heterogeneity in sympathetic innervation worsened. Specifically, both DCM-induced myocyte electrical remodeling and spatially inhomogeneous innervation gradients synergistically worsened arrhythmogenesis. Thus, heterogeneous innervation gradients in DCM promoted arrhythmogenesis. Restoration of homogeneous sympathetic innervation in the failing heart may reduce VAs.

Authors

Al-Hassan J. Dajani, Michael B. Liu, Michael A. Olaopa, Lucian Cao, Carla Valenzuela-Ripoll, Timothy J. Davis, Megan D. Poston, Elizabeth H. Smith, Jaime Contreras, Marissa Pennino, Christopher M. Waldmann, Donald B. Hoover, Jason T. Lee, Patrick Y. Jay, Ali Javaheri, Roger Slavik, Zhilin Qu, Olujimi A. Ajijola

×

Figure 1

Transgenic DCM mouse model recapitulates human heart failure.

Options: View larger image (or click on image) Download as PowerPoint
Transgenic DCM mouse model recapitulates human heart failure.
(A) Contro...
(A) Control (top row) and DCM (bottom row) mouse hearts imaged using a light microscope. (B) Digitally scanned images of transmural myocardial sections from control and DCM mice in early (left) and late (right) stages stained with Masson’s trichrome to indicate fibrosis. Image scale bars are 100 μm. (C) Images of left ventricular end systolic diameter (ESD, left) and end diastolic diameter (EDD, right) taken using echocardiography for control and DCM mice. Image scale bars are 2 mm. (D) Fibrosis levels in WT vs. DCM in myocardium of left ventricle in early (left, n = 5 for control, n = 7 for DCM, **P = 0.0045, Shapiro-Wilk test, Welch’s t test) and late stages (right, n = 6 for control, n = 5 DCM, ***P < 0.0001, Shapiro-Wilk test, Welch’s t test). LVEF (%) in control and DCM mice in early (left, n = 8 for control, n = 8 for DCM, ***P < 0.0001, Shapiro-Wilk test, Welch’s t test) and late stages (right, n = 8 for control, n = 8 for DCM, ***P < 0.0001, Shapiro-Wilk test, Welch’s t test). EDD in WT vs. DCM mice in early (left, n = 8 for control, n = 8 for DCM, ***P < 0.0001, Shapiro-Wilk test, Welch’s t test) and late stages (right, n = 8 for control, n = 8 for DCM, ***P < 0.0001, Shapiro-Wilk test, Welch’s t test). “Early” refers to mice less than or equal to 8 weeks of age, while “late” refers to mice older than 8 weeks.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts